APA ציטוט

Pradat, P., Virlogeux, V., Maynard, M., Leclercq, M., Hatu, G., Amiri, M., . . . Bailly, F. (2015). Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy. Hepat Mon.

Citação norma Chicago

Pradat, Pierre, et al. "Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy." Hepat Mon 2015.

ציטוט MLA

Pradat, Pierre, et al. "Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy." Hepat Mon 2015.